Novo Nordisk A/s Stock Forecast

Buy or Hold candidate since Jun 22, 2026 Gain 7.53%

The Novo Nordisk A/S stock price gained 2.82% on the last trading day (Monday, 13th Jul 2026), rising from $48.20 to $49.56. During the last trading day the stock fluctuated 7.00% from a day low at $46.73 to a day high of $50.00. The price has risen in 6 of the last 10 days and is up by 3.61% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 592 more shares were traded than the day before. In total, 602 shares were bought and sold for approximately $29.84 thousand.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $50.37 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 18.82% during the next 3 months and, with a 90% probability hold a price between $52.59 and $59.85 at the end of this 3-month period.

NONOF Signals & Forecast

The Novo Nordisk A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $49.01 and $45.51. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Novo Nordisk A/S has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -0.572%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Novo Nordisk A/S stock

On the downside, the stock finds support just below today's level from accumulated volume at $44.52 and $44.19. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Novo Nordisk A/S finds support just below today's level at $44.52. If this is broken, then the next support from accumulated volume will be at $44.19 and $38.82.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.27 between high and low, or 7.00%. For the last week, the stock has had daily average volatility of 4.54%.

Our recommended stop-loss: $47.68 (-3.80%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (NONOF) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Novo Nordisk A/S to open at $48.76, and during the day (based on 14 day Average True Range), to move between $48.39 and $50.74, which gives a possible trading interval of +/-$2.35 (+/-4.86%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 4.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $49.58 (0.04%) than the support at $44.52 (10.17%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Novo Nordisk A/S stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Novo Nordisk A/S stock to perform well in the short-term.

Current score: 2.403 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $48.76 ( 1.61%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk